IBA

World leader in particle accelerator technology and key player in the fight against cancer IBA (Ion Beam Applications S.A.)

is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approxi

mately 1,600 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

24/04/2026

📢 Press release

The top 250 worldwide cancer specialists converge in Belgium to push the frontiers of proton therapy.

IBA Proton Therapy starts today its Proteus User Meeting 2026. Oncologists, physicists, clinicians from the most prestigious cancer care institutions across the Americas, Europe and Asia-Pacific will gather for the largest meeting of proton therapy experts.

🔗 Read the full press release here: https://www.iba-worldwide.com/top-250-cancer-specialists-converge-belgium-push-frontiers-proton-therapy

22/04/2026

Yesterday, we were honored to welcome His Majesty King Philippe of Belgium to IBA as part of the interregional royal economic visit. 🇧🇪👑

As a university spin‑off, IBA demonstrates how the expertise and dedication of our colleagues turn academic research excellence into a world‑class technology champion, serving a deeply human mission in the fight against cancer. 🔬

07/04/2026

🔬On this World Health Day - “Together for Health. Stand with Science.”, IBA reaffirms the essential role of science in advancing global health.

Every day, our technologies help support diagnosis, treatment, and patient safety worldwide.

Together, we can drive progress and shape a healthier future for all. 🌍

27/03/2026

📢 Press release

IBA delivers strong full-year results for 2025 with solid ex*****on in all segments.

Olivier Legrain, Chief Executive Officer of IBA, commented: "2025 marked a year of strong ex*****on for IBA, with a record revenue and improved profitability, enabling us to deliver on our guidance. Momentum across our core businesses is robust, supported by progress in Proton Therapy and growing engagement in nuclear medicine. With a strengthened financial structure and increased visibility on future activity, we are well positioned to continue executing our strategy with confidence."

🔗 Read the full press release here: https://www.iba-worldwide.com/iba-delivers-strong-fy-2025-results-solid-ex*****on-all-segments

25/03/2026

🌟 Inspiring the next generation of STEM talent

At IBA, we welcome students throughout the year to explore STEM (Science, Technology, Engineering and Mathematics) careers and meet the people behind our technologies. 🔬

Since September, more than 300 students, from universities, secondary schools, and teacher‑training programs, have visited our Louvain‑la‑Neuve site.

🌍 These initiatives reflect IBA’s societal mission, especially at a time when Europe faces a growing need for STEM professionals. Programs like Innovat’her, a dedicated event for secondary‑school girls, also help encourage more young women to pursue these fields.

Thank you to all the students for their curiosity, and to our colleagues for making these visits truly inspiring. 🙏

23/03/2026

📢 Press release

IBA Dosimetry has launched myQA MatriXX AiR to advance patient‑specific quality assurance in particle therapy.

🔗 Read the full press release here: https://www.iba-worldwide.com/iba-launches-myqa-matrixx-air-advance-patient-specific-qa-particle-therapy

20/03/2026

📢 Press release

IBA RadioPharma Solutions announces that Telix Pharmaceutical Limited has selected IBA Cyclone® KIUBE to support manufacturing expansion in the U.S.

🔗 Read the full press release here: https://www.iba-worldwide.com/telix-selects-iba-cycloner-kiube-support-manufacturing-expansion-us

08/03/2026

🌟This International Women’s Day, we celebrate the female scientists whose ideas power IBA’s patented innovations.
At IBA, innovation is powered by talented women whose work contributes to key patented technologies across accelerators, cancer care, environmental and industrial solutions. 🔬

This year’s theme, “Give to Gain,” reminds us that when scientists share their knowledge and creativity, the world gains new possibilities. 🌍

19/02/2026

📢 Press release

IBA RadioPharma Solutions and Shreeji sign multi‑site agreement for four cyclotrons to expand PET radiopharmaceutical manufacturing across India.

🔗 Read the full press release here: https://www.iba-worldwide.com/iba-and-shreeji-sign-multi-site-agreement-four-cyclotrons-expand-pet-radiopharmaceutical

04/02/2026

🌍🎗️ On World Cancer Day, IBA unites to support everyone whose life has been impacted.

Today, IBA colleagues join the “Cancer turned my world upside down” challenge to show their solidarity. 🤝

As a company committed to advancing cancer care, from diagnosis to treatment, we know how deeply this disease can disrupt lives.

Today and every day, we stand with all those affected. 🧡

02/02/2026

📢 Press release

Last Thursday, IBA Proton Therapy announced it has signed a contract for the supply of a Proteus®ONE proton therapy solution to be installed at the MacKay Memorial Hospital in New Taipei City, Taiwan.

🔗 Read the full press release here: https://www.iba-worldwide.com/iba-signs-contract-proteusrone-proton-therapy-system-be-located-mackay-memorial-hospital-new-taipei

05/01/2026

Starting the year with good news!

In late December, IBA Proton Therapy announced it has signed a contract with The Catholic University of Korea, Seoul St.Mary's Hospital, one of the largest hospital in South Korea, for a Proteus®PLUS solution.

🔗 Read the full press release here: https://www.iba-worldwide.com/iba-signs-contract-three-room-proteusrplus-solution-be-installed-seoul-st-marys-hospital

Adres

Louvain-la-Neuve

Website

http://www.iba-worldwide.com/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer IBA nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.